| 1 |
Fang Y, Li Y, Liang H, Li W, Zhang H. Preparation and Preliminary Evaluation of a Promising 99mTc-Labeled Isonitrile-Containing 6-Thia-Fatty Acid Derivative for Myocardial Metabolism Imaging. J Med Chem 2023. [DOI: 10.1021/acs.jmedchem.2c01853] [Reference Citation Analysis]
|
| 2 |
Moscatelli S, Bianco F, Cimini A, Panebianco M, Leo I, Bucciarelli-Ducci C, Perrone MA. The Use of Stress Cardiovascular Imaging in Pediatric Population. Children (Basel) 2023;10. [PMID: 36832347 DOI: 10.3390/children10020218] [Reference Citation Analysis]
|
| 3 |
Sarkar P, Khatana S, Mukherjee B, Shukla J, Das B, Dutta G. Application of Radiopharmaceuticals in Diagnostics and Therapy. Next-Generation Nanobiosensor Devices for Point-Of-Care Diagnostics 2023. [DOI: 10.1007/978-981-19-7130-3_10] [Reference Citation Analysis]
|
| 4 |
Kusmirek JE, Mcmillan AB. Cardiac PET/MR. Advances in Clinical Radiology 2022;4:87-109. [DOI: 10.1016/j.yacr.2022.04.008] [Reference Citation Analysis]
|
| 5 |
Damasceno A, Pijeira MSO, Ricci-junior E, Alencar LMR, İlem-özdemir D, Santos-oliveira R. Exploiting the Extemporaneousness of Radiopharmaceuticals: Radiolabeling Stability under Diverse Conditions. Journal of Pharmaceutical and Biomedical Analysis 2022. [DOI: 10.1016/j.jpba.2022.115024] [Reference Citation Analysis]
|
| 6 |
Muranaka Y, Mizutani A, Kobayashi M, Nakamoto K, Matsue M, Takagi F, Okazaki K, Nishi K, Yamazaki K, Nishii R, Shikano N, Okamoto S, Maki H, Kawai K. 123I-BMIPP, a Radiopharmaceutical for Myocardial Fatty Acid Metabolism Scintigraphy, Could Be Utilized in Bacterial Infection Imaging. Pharmaceutics 2022;14:1008. [DOI: 10.3390/pharmaceutics14051008] [Reference Citation Analysis]
|
| 7 |
Toner YC, Ghotbi AA, Naidu S, Sakurai K, van Leent MMT, Jordan S, Ordikhani F, Amadori L, Sofias AM, Fisher EL, Maier A, Sullivan N, Munitz J, Senders ML, Mason C, Reiner T, Soultanidis G, Tarkin JM, Rudd JHF, Giannarelli C, Ochando J, Pérez-Medina C, Kjaer A, Mulder WJM, Fayad ZA, Calcagno C. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation. Sci Rep 2022;12:6185. [PMID: 35418569 DOI: 10.1038/s41598-022-09590-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 8 |
Manabe O, Naya M. Potential of 18F-FDG PET to evaluate the cardiocerebral interaction. J Nucl Cardiol 2022;29:489-491. [DOI: 10.1007/s12350-020-02302-1] [Reference Citation Analysis]
|
| 9 |
Wachabauer D, Beyer T, Ditto M, Gallowitsch HJ, Hinterreiter M, Ibi B, Malle P, Mirzaei S, Smetana F, Staudenherz A, Warwitz B, Zettinig G, Rausch I. Diagnostic Reference Levels for nuclear medicine imaging in Austria: A nationwide survey of used dose levels for adult patients. Z Med Phys 2022;32:283-95. [PMID: 35067426 DOI: 10.1016/j.zemedi.2021.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Santoro F, Mallardi A, Leopizzi A, Vitale E, Stiermaier T, Trambaiolo P, Di Biase M, Eitel I, Brunetti ND. Stepwise approach for diagnosis and management of Takotsubo syndrome with cardiac imaging tools. Heart Fail Rev 2022. [PMID: 35040000 DOI: 10.1007/s10741-021-10205-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Kamani CH, Prior JO. Rubidium-82 PET/CT myocardial perfusion imaging. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00091-0] [Reference Citation Analysis]
|
| 12 |
Mahmood A, Srivastava R. Medical diagnosis of cancer. Understanding Cancer 2022. [DOI: 10.1016/b978-0-323-99883-3.00017-2] [Reference Citation Analysis]
|
| 13 |
Avraham E, Meyerstein D, Lerner A, Yardeni G, Pevzner S, Zilbermann I, Moisy P, Maimon E, Popivker I. Reactions of methyl, hydroxyl and peroxyl radicals with the DOTA chelating agent used in medical imaging. Free Radic Biol Med 2021:S0891-5849(21)01174-6. [PMID: 34973364 DOI: 10.1016/j.freeradbiomed.2021.12.313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Manabe O, Naya M, Aikawa T, Oyama-manabe N. Differential diagnosis of cardiac disease with <sup>18</sup>F-FDG accumulation. JJSOGD 2021;41:39-44. [DOI: 10.7878/jjsogd.41.1_2_39] [Reference Citation Analysis]
|
| 15 |
Fesas A, Giannoula E, Vrachimis A, Doumas A, Wenning C, Didagelos M, Iakovou I. Cardiac Autonomic Nervous System and Ventricular Arrhythmias: The Role of Radionuclide Molecular Imaging. Diagnostics (Basel) 2021;11:1273. [PMID: 34359356 DOI: 10.3390/diagnostics11071273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Tsuchiya J, Moriyama S, Manabe O, Amemiya M, Yokoyama K, Kimura K, Fujii Y, Tateishi U. What is this image? 2021 image 1 result : A rare case of right ventricular metastasis in renal cell carcinoma detected by thallium-201 scintigraphy. J Nucl Cardiol 2021;28:1213-5. [PMID: 34109504 DOI: 10.1007/s12350-021-02694-8] [Reference Citation Analysis]
|
| 17 |
Bays HE, Khera A, Blaha MJ, Budoff MJ, Toth PP. Ten things to know about ten imaging studies: A preventive cardiology perspective ("ASPC top ten imaging"). Am J Prev Cardiol 2021;6:100176. [PMID: 34327499 DOI: 10.1016/j.ajpc.2021.100176] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 18 |
Kang KW, Venkatesh M. Medicine: Radiopharmaceuticals and Their Use in Nuclear Medicine. Encyclopedia of Nuclear Energy 2021. [DOI: 10.1016/b978-0-12-819725-7.00176-8] [Reference Citation Analysis]
|
| 19 |
Bois JP, Gropler RJ. CardiacApplications of Radiopharmaceuticals. Handbook of Radiopharmaceuticals 2020. [DOI: 10.1002/9781119500575.ch20] [Reference Citation Analysis]
|
| 20 |
Villemain O, Baranger J, Jalal Z, Lam C, Calais J, Pernot M, Cifra B, Friedberg MK, Mertens L. Non-invasive imaging techniques to assess myocardial perfusion. Expert Rev Med Devices 2020;17:1133-44. [PMID: 33044100 DOI: 10.1080/17434440.2020.1834844] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 21 |
Manabe O, Naya M, Aikawa T, Tamaki N. Recent advances in cardiac positron emission tomography for quantitative perfusion analyses and molecular imaging. Ann Nucl Med 2020;34:697-706. [DOI: 10.1007/s12149-020-01519-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Manabe O, Oyama-Manabe N, Tamaki N. Positron emission tomography/MRI for cardiac diseases assessment. Br J Radiol 2020;93:20190836. [PMID: 32023123 DOI: 10.1259/bjr.20190836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 23 |
Marker SC, King AP, Granja S, Vaughn B, Woods JJ, Boros E, Wilson JJ. Exploring the In Vivo and In Vitro Anticancer Activity of Rhenium Isonitrile Complexes. Inorg Chem 2020;59:10285-303. [PMID: 32633531 DOI: 10.1021/acs.inorgchem.0c01442] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 24 |
Régis C, Martineau P, Harel F, Pelletier-galarneau M. Personalized Cardiac Imaging with New PET Radiotracers. Curr Cardiovasc Imaging Rep 2020;13. [DOI: 10.1007/s12410-020-9530-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 25 |
Tong D, Zaha VG. Metabolic Imaging in Cardio-oncology. J Cardiovasc Transl Res 2020;13:357-66. [PMID: 31696405 DOI: 10.1007/s12265-019-09927-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 26 |
Kumita S, Yoshinaga K, Miyagawa M, Momose M, Kiso K, Kasai T, Naya M; Committee for diagnosis of cardiac sarcoidosis using 18F-FDG PET, Japanese Society of Nuclear Cardiology. Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis—2018 update: Japanese Society of Nuclear Cardiology recommendations. J Nucl Cardiol 2019;26:1414-33. [DOI: 10.1007/s12350-019-01755-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 27 |
Williams MC, Stewart C, Weir NW, Newby DE. Using radiation safely in cardiology: what imagers need to know. Heart 2019;105:798-806. [PMID: 30777934 DOI: 10.1136/heartjnl-2017-312493] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 28 |
Manabe O, Naya M, Aikawa T, Yoshinaga K. <sup>15</sup>O-labeled Water is the Best Myocardial Blood Flow Tracer for Precise MBF Quantification. Annals of Nuclear Cardiology 2019;5:69-72. [DOI: 10.17996/anc.18-00064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Kumita S, Yoshinaga K, Miyagawa M, Momose M, Kiso K, Kasai T, Naya M. Recommendations for <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography Imaging for Diagnosis of Cardiac Sarcoidosis—2018 Update. Annals of Nuclear Cardiology 2019;5:141-159. [DOI: 10.17996/anc.19-00092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 30 |
Gullberg GT, Shrestha UM, Seo Y. PET imaging of glucose and fatty acid metabolism for NAFLD patients. J Nucl Cardiol 2020;27:1689-97. [PMID: 30547298 DOI: 10.1007/s12350-018-01532-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 31 |
Tamaki N, Matsushima S, Yoshinaga K. Perspectives of quantitative assessment of myocardial blood flow. Clin Transl Imaging 2018;6:321-7. [DOI: 10.1007/s40336-018-0287-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 32 |
Manabe O, Naya M, Oyama-Manabe N, Koyanagawa K, Tamaki N. The role of multimodality imaging in takotsubo cardiomyopathy. J Nucl Cardiol 2019;26:1602-16. [PMID: 29858766 DOI: 10.1007/s12350-018-1312-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
|
